Cargando…
Endothelial progenitor cells in cardiovascular diseases: from biomarker to therapeutic agent
Regenerative medicine techniques to recover cardiac and vascular function are being increasingly investigated as management strategies for cardiovascular diseases. Circulating endothelial progenitor cells (EPCs) derived from bone marrow are immature cells capable of differentiating into mature endot...
Autores principales: | Liu, Hui-Bin, Gong, Yuan-Feng, Yu, Chang-Jiang, Sun, Ying-Ying, Li, Xin-Yuan, Zhao, Dan, Zhang, Zhi-Ren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430916/ https://www.ncbi.nlm.nih.gov/pubmed/25984328 http://dx.doi.org/10.1186/2050-490X-1-9 |
Ejemplares similares
-
Endothelial progenitor cells as biomarkers of diabetes-related cardiovascular complications
por: Benítez-Camacho, Josefa, et al.
Publicado: (2023) -
Endothelial Progenitor Cells as Biomarkers of Cardiovascular Pathologies: A Narrative Review
por: Heinisch, Paul Philipp, et al.
Publicado: (2022) -
Endothelial Progenitor Cells and Cardiovascular Correlates
por: Mudyanadzo, Tatenda A
Publicado: (2018) -
Endothelial progenitor cells in cardiovascular diseases
por: Qiu, Yumin, et al.
Publicado: (2018) -
Endothelial Progenitor Cells: New Targets for Therapeutics for Inflammatory Conditions With High Cardiovascular Risk
por: Edwards, Nicola, et al.
Publicado: (2018)